Hong Kong, Macau suspend BioNTech vaccines for packaging error

Hong Kong and Macau have temporarily discontinued the Covid vaccines manufactured by BioNTech SE due to a packaging flaw, which dealt a blow to the cities’ efforts to revive their pandemic-torn economies.

Both governments said on Wednesday that they have received reports of defects in the packaging of vials Shanghai Fosun Pharmaceutical Group Co., which has the rights to develop and market the shots in mainland China, Hong Kong, Macau and Taiwan. BioNTech and Fosun Pharma have launched an investigation into the problem and say there is no reason to believe product safety is at risk, the Macau government statement said.

Hong Kong suspends BioNTech vaccines for packaging error

A community vaccination center administering the BioNTech Covid-19 is temporarily closed on March 24.

Photographer: Kyle Lam / Bloomberg

The suspension marks the latest setback for the introduction of vaccines in Hong Kong, which has been delayed by public mistrust in the Beijing-backed government. While the shot of the BioNTech shot started to surpass that of the shots of a Chinese company Sinovac Biotech Ltd., concerns about the packaging error, threatens to undermine public confidence in both options.

Source